Specialty Enzymes

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability And Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions And Scope Of Study
• Specialty Medical Enzymes
• Polymerases
• Nucleases
• Other Specialty Enzymes
• Pharmaceuticals/Diagnostic
• Research/Biotechnology

II. EXECUTIVE SUMMARY

1. Introduction

2. Global Market Overview

3. Enzymes- A Review

• Definition
• Introduction
• Advantages of Enzymes Compared to Chemical Catalysts
• Table 1: Enzymes Market Worldwide (2005 & 2006): Market Share of Leading Players- Novozymes, Genencol, DSM, BASF and Others (includes corresponding Graph/Chart)
• A Brief History

4. Specialty Enzymes: An Overview

• Analysis of Product Segments
• Specialty Medical Enzymes
• Polymerases
• Nucleases
• Other Specialty Enzymes

5. Analysis of the End-Use Markets

• Pharmaceuticals & Diagnostics
• Research/Biotechnology
• Other End Use Markets

6. Technology Trends

• Protein Engineering Technology
• Specialty Enzymes in Industrial Uses
• Enzyme Technology in Pig Industry

7. Product Innovations/Introductions

• MARDI Develops Taq DNA Polymerase
• Stratagene Corporation Commercializes DNA Polymerases
• Takara Bio Launches PrimeSTAR HS DNA Polymerase
• Verdia and Pioneer Hi-Bred International Develops Glyphosate-Resistant Crop Trait
• Novozymes Creates Lipase Enzyme

8. Recent Industry Activity

• Inverness Medical Innovations Acquires BBI Holdings Plc
• Helix Biopharma Enters into a Contract with KBI Biopharma
• Verenium Enters into Agreement with Bunge Oils
• BBI Holdings Acquires Theratase Plc
• Danisco to Acquire Stake in South African Firm
• Affymetrix to Buy USB Corporation
• Diversa Merges with Celunol to Form Verenium Corporation
• Diversa Collaborates with BASF
• Codexis Expands Collaboration with Royal Dutch Shell to Develop Super Enzymes
• Diversa Enters into a Deal with Syngenta to Develop Enzymes
• Genencor Begins Operation at New China Site and Introduces a New Detergent Enzyme
• Verenium Receives $4.6 million For Enzyme Development
• Biocon Divests its Enzymes Business to Novozymes
• Solexa Signs Agreement with New England Biolabs
• Danisco Takes Over Genencor
• IBEX Technologies Inks Agreement with Cape Cod and Prozyme

9. Focus on Select Players Worldwide

• Advanced Enzymes Technologies Limited (India)
• Amano Enzyme Inc. (Japan)
• Aureozyme Inc. (USA)
• Biocon Ltd. (India)
• Operational Model of Biocon
• Biozyme Laboratories (UK)
• Danisco (Denmark)
• Genencor (USA)
• Kinetic Biosystems, Inc. (USA)
• Maxygen Inc (USA)
• Codexis Inc. (USA)
• Novozymes (Denmark)
• Seravac Biotech (Pty) Ltd (South Africa)
• Specialty Enzymes and Biochemicals Co. (USA)
• Verenium Corporation (USA)

10. Global Market Perspective

• Table 2: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 3: World Long-term Projections for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 4: World 10-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 5: World Recent Past, Current & Future Analysis for Specialty Medical Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 6: World Long-term Projections for Specialty Medical Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 7: World 10-Year Perspective for Specialty Medical Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 8: World Recent Past, Current & Future Analysis for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 9: World Long-term Projections for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 10: World 10-Year Perspective for Polymerases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 11: World Recent Past, Current & Future Analysis for Nucleases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 12: World Long-term Projections for Nucleases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 13: World 10-Year Perspective for Nucleases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 14: World Recent Past, Current & Future Analysis for Other Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 15: World Long-term Projections for Other Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 16: World 10-Year Perspective for Other Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 17: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 18: World Long-term Projections for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 19: World 10-Year Perspective for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 20: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 21: World Long-term Projections for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 22: World 10-Year Perspective for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 23: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 24: World Long-term Projections for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 25: World 10-Year Perspective for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Market Dynamics
  • Specialty Enzymes Market is Projected to Rise 7% Annually
  • Specialty Enzymes Form the Leading Enzymes Segment
  • Pharmaceuticals and Diagnostics Continue to be the Largest Market
  • Specialty Medical Enzymes in a Myriad of Novel Applications
  • Market for Enzymes in Biotechnology
  • Product Launch
  • Strategic Corporate Developments ...
  • Select Players
  • Aureozyme Inc.
  • Genencor.
  • Kinetic Biosystems, Inc.
  • Maxygen Inc
  • Codexis Inc.
  • Specialty Enzymes and Biochemicals Co.
  • Verenium Corporation
• B. Market Analytics
  • Table 26: US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 27: US Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 28: US 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 29: US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 30: US Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 31: US 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Strategic Corporate Development
• B. Market Analytics
  • Table 32: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)
  • Table 33: Canadian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 34: Canadian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 35: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 36: Canadian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 37: Canadian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

3. Japan

• A. Market Analysis
  • Product Launch
  • Amano Enzyme Inc. - A Major Player
• B. Market Analytics
  • Table 38: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 39: Japanese Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 40: Japanese 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 41: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 42: Japanese Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 43: Japanese 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4. Europe

• Market Analysis
• Table 44: European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 45: European Long-term Projections for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 46: European 10-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 47: European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 48: European Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 49: European 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 50: European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 51: European Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 52: European 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4a. France

• Market Analysis
• Table 53: French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 54: French Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 55: French 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 56: French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 57: French Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 58: French 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4b. Germany

• Market Analysis
• Table 59: German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 60: German Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 61: German 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 62: German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 63: German Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 64: German 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4c. Italy

• Market Analysis
• Table 65: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 66: Italian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 67: Italian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 68: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 69: Italian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 70: Italian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4d. The United Kingdom

• A. Market Analysis
  • Biozyme Laboratories Limited - A Major Player
• B. Market Analytics
  • Table 71: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 72: UK Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 73: UK 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 74: UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 75: UK Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 76: UK 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4e. Spain

• Market Analysis
• Table 77: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 78: Spanish Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 79: Spanish 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012(includes corresponding Graph/Chart)
• Table 80: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)
• Table 81: Spanish Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 82: Spanish 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4f. Russia

• Market Analysis
• Table 83: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 84: Russian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 85: Russian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 86: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 87: Russian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 88: Russian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4g. Rest of Europe

• A. Market Analysis
  • Strategic Corporate Development
  • Select Players
  • Danisco (Denmark)
  • Novozymes (Denmark)
• B. Market Analytics
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 90: Rest of Europe Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 91: Rest of Europe 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 93: Rest of Europe Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 94: Rest of Europe 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

5. Asia-Pacific

• A. Market Analysis
  • Enzyme Market in China
  • Product Launch
  • Strategic Corporate Development
  • Select Players
  • Advanced Enzymes Technologies Limited (India)
  • Biocon Ltd. (India)
• B. Market Analytics
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 96: Asia-Pacific Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 97: Asia-Pacific 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 99: Asia-Pacific Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 100: Asia-Pacific 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

6. The Middle East

• Market Analysis
• Table 101: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 102: Middle East Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 103: Middle East 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 104: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)
• Table 105: Middle East Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 106: Middle East 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

7. Latin America

• Market Analysis
• Table 107: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 108: Latin American Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 109: Latin American 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 110: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 111: Latin American Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 112: Latin American 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE